Also trades as: CDIOW (NASDAQ) · $vol 0M
CDIO NASDAQ
Cardio Diagnostics Holdings, Inc.
1W: -24.2%
1M: -29.9%
3M: -35.2%
YTD: -51.4%
1Y: -64.1%
3Y: -97.3%
$1.42
+0.05 (+3.65%)
After Hours: $1.52 (+0.10, +6.69%)
Weekly Expected Move ±8.6%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$2.5M
52W Range0.97-7.91
Volume71,537
Avg Volume2,763,618
Beta2.26
Dividend—
Analyst Ratings
Company Info
CEOMeeshanthini V. Dogan
Employees13
SectorHealthcare
IndustryBiotechnology
IPO Date2022-01-14
Websitecardiodiagnosticsinc.com
400 N Aberdeen St
Chicago, IL 60642
US
Chicago, IL 60642
US
855 226 9991
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
Latest News
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Fung Peter K | A-Award | 3,205 | $1.95 | 2026-03-31 |
| Betts Wendy J | A-Award | 3,205 | $1.95 | 2026-03-31 |
| Intrater James | A-Award | 3,205 | $1.95 | 2026-03-31 |
| Burton Paul Frederic | A-Award | 3,205 | $1.95 | 2026-03-31 |
| Fung Peter K | A-Award | 2,306 | $2.71 | 2025-12-31 |